Related Experiment Videos
Immunoadsorption plasmapheresis for severe generalised myasthenia gravis
1Department of Paediatrics, Shinshu University, School of Medicine, Matsumoto, Japan.
Insights
Immunoadsorption plasmapheresis offers a safe and effective treatment for severe generalized myasthenia gravis in children. This method significantly improved symptoms in two pediatric patients, demonstrating superiority over traditional plasma exchange.
Area of Science:
- Neurology
- Immunology
Background:
- Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions, leading to muscle weakness.
- Severe generalized myasthenia gravis in childhood presents significant challenges in management and treatment.
- Current treatment options like plasma exchange carry risks such as viral infections and hypersensitivity reactions.
Observation:
- Two pediatric patients diagnosed with severe generalized myasthenia gravis were treated using immunoadsorption plasmapheresis.
- One patient was a 5-year-old girl, and the other was a 12-year-old girl.
- Treatment involved the removal of specific antibodies from the blood via immunoadsorption.
Findings:
- Both patients experienced dramatic improvements in bulbar symptoms and generalized muscle weakness.
- The treatment was well-tolerated, with no reported side effects in either patient.
- Immunoadsorption plasmapheresis demonstrated superior safety compared to conventional plasma exchange.
Implications:
- Immunoadsorption plasmapheresis is a highly effective and safe therapeutic option for pediatric severe generalized myasthenia gravis.
- This approach may offer a safer alternative to plasma exchange, reducing the risk of adverse events.
- Further research into immunoadsorption techniques could advance the treatment of autoimmune neuromuscular disorders in children.
Abstract:
Two patients with severe generalised myasthenia gravis of childhood were successfully treated with immunoadsorption plasmapheresis. One patient was a 5 year old girl and the other was a 12 year old girl. A dramatic improvement in bulbar symptoms and generalised muscle weakness was achieved without any side effects. Plasma exchange may also yield clinical improvement for myasthenia gravis, but the treatment is accompanied by the risk of viral infections and hypersensitivity reactions. Immunoadsorption plasmapheresis is an effective treatment for severe generalised myasthenia gravis of childhood and is superior to plasma exchange with respect to safety.